P Csermely, T Korcsmáros, HJM Kiss, G London… - 2013 - linkgroup.hu
Peter Csermely a,⁎, Tamás Korcsmáros a, b, Huba JM Kiss a, c, Gábor London d, Ruth Nussinov e, fa Department of Medical Chemistry, Semmelweis University, PO Box 260, H …
P Csermely, T Korcsmáros, HJ Kiss… - Pharmacology & …, 2013 - europepmc.org
Despite considerable progress in genome-and proteome-based high-throughput screening methods and in rational drug design, the increase in approved drugs in the past decade did …
P Csermely, T Korcsmáros, HJM Kiss… - Pharmacology & …, 2013 - real.mtak.hu
Despite considerable progress in genome-and proteome-based high-throughput screening methods and in rational drug design, the increase in approved drugs in the past decade did …
P Csermely, T Korcsmáros, HJM Kiss, G London… - academia.edu
Despite considerable progress in genome-and proteome-based high-throughput screening methods and in rational drug design, the increase in approved drugs in the past decade did …
P Csermely, T Korcsmáros, HJM Kiss, G London… - Pharmacology and …, 2013 - infona.pl
Despite considerable progress in genome-and proteome-based high-throughput screening methods and in rational drug design, the increase in approved drugs in the past decade did …
P Csermely, T Korcsmáros, HJM Kiss, G London… - researchgate.net
Despite considerable progress in genome-and proteome-based high-throughput screening methods and in rational drug design, the increase in approved drugs in the past decade did …
P Csermely, T Korcsmaros, HJM Kiss, G London… - arXiv preprint arXiv …, 2012 - arxiv.org
Despite considerable progress in genome-and proteome-based high-throughput screening methods and in rational drug design, the increase in approved drugs in the past decade did …
P Csermely, T Korcsmáros, HJM Kiss, G London… - 2013 - linkgroup.hu
Peter Csermely a,⁎, Tamás Korcsmáros a, b, Huba JM Kiss a, c, Gábor London d, Ruth Nussinov e, fa Department of Medical Chemistry, Semmelweis University, PO Box 260, H …
P Csermely, T Korcsmaros, HJM Kiss… - Pharmacology and …, 2013 - hero.epa.gov
Despite considerable progress in genome-and proteome-based high-throughput screening methods and in rational drug design, the increase in approved drugs in the past decade did …